149 related articles for article (PubMed ID: 37908982)
1. Successful Management of Cushing Syndrome From Ectopic ACTH Secretion in an Adolescent With Osilodrostat.
Blew K; Van Mater D; Page L
JCEM Case Rep; 2023 Jul; 1(4):luad101. PubMed ID: 37908982
[TBL] [Abstract][Full Text] [Related]
2. A Case of an Ectopic ACTH-Producing Tumor With Adrenal Shrinkage During Osilodrostat Administration.
Sawabe F; Hayafusa R; Kosugi R; Ariyasu H
JCEM Case Rep; 2024 Feb; 2(2):luae008. PubMed ID: 38283731
[TBL] [Abstract][Full Text] [Related]
3. Unusual cause of ectopic secretion of adrenocorticotropic hormone: Cushing syndrome attributable to small cell prostate cancer.
Alshaikh OM; Al-Mahfouz AA; Al-Hindi H; Mahfouz AB; Alzahrani AS
Endocr Pract; 2010; 16(2):249-54. PubMed ID: 20061271
[TBL] [Abstract][Full Text] [Related]
4. Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study.
Creemers SG; Feelders RA; de Jong FH; Franssen GJH; de Rijke YB; van Koetsveld PM; Hofland LJ
J Clin Endocrinol Metab; 2019 Aug; 104(8):3437-3449. PubMed ID: 31127821
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France.
Dormoy A; Haissaguerre M; Vitellius G; Do Cao C; Geslot A; Drui D; Lasolle H; Vieira-Pinto O; Salenave S; François M; Puerto M; Boullay HD; Mayer A; Rod A; Laurent C; Chanson P; Reznik Y; Castinetti F; Chabre O; Baudin E; Raverot G; Tabarin A; Young J
J Clin Endocrinol Metab; 2023 May; 108(6):1475-1487. PubMed ID: 36470583
[TBL] [Abstract][Full Text] [Related]
6. Ectopic ACTH-secreting pituitary adenoma of the sphenoid sinus: case report of endoscopic endonasal resection and systematic review of the literature.
Seltzer J; Lucas J; Commins D; Lerner O; Lerner A; Carmichael JD; Zada G
Neurosurg Focus; 2015 Feb; 38(2):E10. PubMed ID: 25639312
[TBL] [Abstract][Full Text] [Related]
7. Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome.
Landry JP; Clemente-Gutierrez U; Pieterman CRC; Chiang YJ; Waguespack SG; Jimenez C; Habra MA; Halperin DM; Fisher SB; Graham PH; Perrier ND
Surgery; 2022 Aug; 172(2):559-566. PubMed ID: 35437162
[TBL] [Abstract][Full Text] [Related]
8. Recurrent acute-onset Cushing's syndrome 6 years after removal of a thymic neuroendocrine carcinoma: from ectopic ACTH to CRH.
Schalin-Jäntti C; Asa SL; Arola J; Sane T
Endocr Pathol; 2013 Mar; 24(1):25-9. PubMed ID: 23233312
[TBL] [Abstract][Full Text] [Related]
9. ECTOPIC CUSHING SYNDROME: A 10-YEAR EXPERIENCE FROM A TERTIARY CARE CENTER IN SOUTHERN INDIA.
Sathyakumar S; Paul TV; Asha HS; Gnanamuthu BR; Paul MJ; Abraham DT; Rajaratnam S; Thomas N
Endocr Pract; 2017 Aug; 23(8):907-914. PubMed ID: 28614007
[TBL] [Abstract][Full Text] [Related]
10. Adrenal Cushing's Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy.
Malik RB; Ben-Shlomo A
AACE Clin Case Rep; 2022; 8(6):267-270. PubMed ID: 36447826
[TBL] [Abstract][Full Text] [Related]
11. Severe ectopic Cushing syndrome in a transgender man with a metastatic gastrinoma and an adrenal tumor-A case report and review of the literature.
Wydra A; Cylke-Falkowska K; Czajka-Oraniec I; Kolasińska-Ćwikła A; Ćwikła J; Zgliczyński W; Stelmachowska-Banaś M
Front Endocrinol (Lausanne); 2023; 14():1135016. PubMed ID: 37008936
[TBL] [Abstract][Full Text] [Related]
12. Osilodrostat: A Review of Recent Clinical Studies and Practical Recommendations for its Use in the Treatment of Cushing Disease.
Yuen KCJ
Endocr Pract; 2021 Sep; 27(9):956-965. PubMed ID: 34389514
[TBL] [Abstract][Full Text] [Related]
13. Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients.
Bonnet-Serrano F; Poirier J; Vaczlavik A; Laguillier-Morizot C; Blanchet B; Baron S; Guignat L; Bessiene L; Bricaire L; Groussin L; Assié G; Guibourdenche J; Bertherat J
Eur J Endocrinol; 2022 Aug; 187(2):315-322. PubMed ID: 35699971
[TBL] [Abstract][Full Text] [Related]
14. Persistent hypokalemia after successful adrenalectomy in a patient with Cushing's syndrome due to ectopic ACTH secretion: possible role of 11beta-hydroxysteroid dehydrogenase inhibition.
Arteaga E; Fardella C; Campusano C; Cárdenas I; Martinez P
J Endocrinol Invest; 1999 Dec; 22(11):857-9. PubMed ID: 10710274
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole treatment in severe ectopic Cushing syndrome.
Canteros TM; De Miguel V; Fainstein-Day P
Endocrinol Diabetes Metab Case Rep; 2019 Jul; 2019(1):. PubMed ID: 31373475
[TBL] [Abstract][Full Text] [Related]
16. The first description of metyrapone use in severe Cushing Syndrome due to ectopic ACTH secretion in an infant with immature sacrococcygeal teratoma. Case Report.
Wojcik M; Kalicka-Kasperczyk A; Luszawska-Kutrzeba T; Balwierz W; Starzyk JB
Neuro Endocrinol Lett; 2015 Dec; 36(7):653-5. PubMed ID: 26859587
[TBL] [Abstract][Full Text] [Related]
17. [The ectopic ACTH syndrome].
Penezić Z; Savić S; Vujović S; Tatić S; Ercegovac M; Drezgićc M
Srp Arh Celok Lek; 2004; 132(1-2):28-32. PubMed ID: 15227962
[TBL] [Abstract][Full Text] [Related]
18. Clinical Utility of Osilodrostat in Cushing's Disease: Review of Currently Available Literature.
Perosevic M; Tritos NA
Drug Des Devel Ther; 2023; 17():1303-1312. PubMed ID: 37143705
[TBL] [Abstract][Full Text] [Related]
19. Bilateral adrenalectomy: lifesaving procedure in severe Cushing syndrome.
Han JY; Mirsadraei L; Yeh MW; Suh JD; Yong WH; Bergsneider M; Heaney AP
Endocr Pract; 2012; 18(4):e85-90. PubMed ID: 22441001
[TBL] [Abstract][Full Text] [Related]
20. Medullary thyroid carcinoma with ectopic adrenocorticotropic hormone syndrome.
Choi HS; Kim MJ; Moon CH; Yoon JH; Ku HR; Kang GW; Na II; Lee SS; Lee BC; Park YJ; Kim HI; Ku YH
Endocrinol Metab (Seoul); 2014 Mar; 29(1):96-100. PubMed ID: 24741461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
